NOVAVAX INC
NVAXBiological Products, (No Diagnostic Substances) · SIC 2836 · CIK 0001000694
Revenue FY2025
$1.12B
Net Income
$0.44B
EPS (Basic)
$2.72
Net Margin
39.2%
ROE
-344.7%
Total Equity
$(0.13B)
Shares Out
165M
NOVAVAX INC — Biological Products, (No Diagnostic Substances). Figures are as reported in each year's original 10-K via SEC EDGAR XBRL company facts (FY2009–FY2025; structured XBRL data begins around 2008). Market-price metrics are not part of EDGAR data.
Revenue & Net Income (10Y)
Margin Trends
Investor Ownership · 1 fund in our universe
FundPosition Value% of AUMQoQ ChgWeight
Coatue Management
Philippe Laffont
$36.1M
0.0%
—
Insider Transactions
Reading stored insider transactions…